Pten	O
signaling	O
in	O
gliomas	B-Cancer
.	O

In	O
1997	O
,	O
the	O
PTEN	O
gene	O
(	O
phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
10	O
)	O
was	O
identified	O
as	O
a	O
tumor	B-Cancer
suppressor	O
gene	O
on	O
the	O
long	O
arm	O
of	O
chromosome	B-Cellular_component
10	I-Cellular_component
.	O

Since	O
then	O
,	O
important	O
progress	O
has	O
been	O
made	O
with	O
respect	O
to	O
the	O
understanding	O
of	O
the	O
role	O
of	O
the	O
Pten	O
protein	O
in	O
the	O
normal	O
development	O
of	O
the	O
brain	B-Organ
as	O
well	O
as	O
in	O
the	O
molecular	O
pathogenesis	O
of	O
human	O
gliomas	B-Cancer
.	O

This	O
review	O
summarizes	O
the	O
current	O
state	O
of	O
the	O
art	O
concerning	O
the	O
involvement	O
of	O
aberrant	O
Pten	O
function	O
in	O
the	O
development	O
of	O
different	O
biologic	O
features	O
of	O
malignant	B-Cancer
gliomas	I-Cancer
,	O
such	O
as	O
loss	O
of	O
cell	B-Cell
-	O
cycle	O
control	O
and	O
uncontrolled	O
cell	B-Cell
proliferation	O
,	O
escape	O
from	O
apoptosis	O
,	O
brain	B-Organ
invasion	O
,	O
and	O
aberrant	O
neoangiogenesis	O
.	O

Most	O
of	O
the	O
tumor	B-Cancer
-	O
suppressive	O
properties	O
of	O
Pten	O
are	O
dependent	O
on	O
its	O
lipid	O
phosphatase	O
activity	O
,	O
which	O
inhibits	O
the	O
phosphatidylinositol	O
-	O
3	O
'	O
-	O
kinase	O
(	O
PI3K	O
)	O
/	O
Akt	O
signaling	O
pathway	O
through	O
dephosphorylation	O
of	O
phosphatidylinositol	O
-	O
(	O
3	O
,	O
4	O
,	O
5	O
)	O
-	O
triphosphate	O
.	O

The	O
additional	O
function	O
of	O
Pten	O
as	O
a	O
dual	O
-	O
specificity	O
protein	O
phosphatase	O
may	O
also	O
play	O
a	O
role	O
in	O
glioma	B-Cancer
pathogenesis	O
.	O

Besides	O
the	O
wealth	O
of	O
data	O
elucidating	O
the	O
functional	O
roles	O
of	O
Pten	O
,	O
recent	O
studies	O
suggest	O
a	O
diagnostic	O
significance	O
of	O
PTEN	O
gene	O
alterations	O
as	O
a	O
molecular	O
marker	O
for	O
poor	O
prognosis	O
in	O
anaplastic	B-Cancer
astrocytomas	I-Cancer
and	O
anaplastic	B-Cancer
oligodendrogliomas	I-Cancer
.	O

Furthermore	O
,	O
the	O
possibility	O
of	O
selective	O
targeting	O
of	O
PTEN	B-Cell
mutant	I-Cell
tumor	I-Cell
cells	I-Cell
by	O
specific	O
pharmacologic	O
inhibitors	O
of	O
members	O
of	O
the	O
Pten	O
/	O
PI3K	O
/	O
Akt	O
pathway	O
opens	O
up	O
new	O
perspectives	O
for	O
a	O
targeted	O
molecular	O
therapy	O
of	O
malignant	B-Cancer
gliomas	I-Cancer
.	O

